Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis.
about
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes"Iron-saturated" bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice.Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patientsEvidence for the existence of triple-negative variants in the MCF-7 breast cancer cell population.Risk of second breast cancer according to estrogen receptor status and family history.Granulosa cell tumor of the ovary after long-term use of tamoxifen and toremifene.
P2860
Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Tamoxifen may prevent both ER+ ...... sis: an alternative hypothesis
@nl
Tamoxifen may prevent both ER+ ...... is: an alternative hypothesis.
@ast
Tamoxifen may prevent both ER+ ...... is: an alternative hypothesis.
@en
type
label
Tamoxifen may prevent both ER+ ...... sis: an alternative hypothesis
@nl
Tamoxifen may prevent both ER+ ...... is: an alternative hypothesis.
@ast
Tamoxifen may prevent both ER+ ...... is: an alternative hypothesis.
@en
prefLabel
Tamoxifen may prevent both ER+ ...... sis: an alternative hypothesis
@nl
Tamoxifen may prevent both ER+ ...... is: an alternative hypothesis.
@ast
Tamoxifen may prevent both ER+ ...... is: an alternative hypothesis.
@en
P2093
P2860
P3181
P356
P1476
Tamoxifen may prevent both ER+ ...... is: an alternative hypothesis.
@en
P2093
Elissa M Ozanne
Joyce M Slingerland
Laura J Esserman
P2860
P2888
P304
P3181
P356
10.1186/BCR1342
P407
P577
2005-11-21T00:00:00Z
P5875
P6179
1052818717